Home > Insider Trading > Filing (0001209191-14-054311)

Filing Details

Accession Number:: 0001209191-14-054311
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-25 18:29:39
Reporting Period:: 2014-08-21

Filing Date:: 2014-08-25
Accepted Time:: 2014-08-25 18:29:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1110780	Carl Goldfischer	11 Belvedere Ave Belvedere CA 94920		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-21	37,943	$33.04	3,154,119	No	4	S	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-21	723	$33.04	3,153,396	No	4	S	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-22	125,606	$32.46	3,027,790	No	4	S	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-22	2,394	$32.46	3,025,396	No	4	S	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-25	195,377	$35.13	2,830,019	No	4	S	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-25	3,723	$35.13	2,826,296	No	4	S	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-25	883	$36.40	2,825,413	No	4	S	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-08-25	17	$36.40	2,825,396	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.75 per share to $33.50 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents shares held by Bay City Capital Fund V, L.P. ("Fund V"); and indirect interests of Bay City Capital LLC ("BCC"), the manager of Bay City Capital Management V LLC ("Management V"), and Management V, the general partner of Fund V. Dr. Goldfischer is Managing Director of BCC. Dr. Goldfischer, BCC and Management V each disclaims beneficial ownership in such shares, except to the extent of their pecuniary interest therein.
Represents shares held by Bay City Capital Fund V Co-Investment Fund, L.P. ("Co-Investment V"); and indirect interests of BCC, the manager of Management V, and Management V, the general partner of Co-Investment V. Dr. Goldfischer is Managing Director of BCC. Dr. Goldfischer, BCC and Management V each disclaims beneficial ownership in such shares, except to the extent of their pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.40 per share to $33.00 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.085 per share to $35.96 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 per share to $36.405 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.